A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
Proteomics uncovered nearly 200 proteins that fluctuate across the menstrual cycle, offering new clues into reproductive ...
Chinese battery giants are increasingly adding sodium-ion cells to their stack – but what can they actually deliver?
Madhu Gaganam, founder and CEO of Cogniedge.ai, said the industry’s shift toward cobots demands more than safer cages or ...
As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case ...
High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly O ...
Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...
The problem of demand outstripping supply capacity is a tale that has become all-too-common across the major AI providers.
The launch and operational start of the Eagle Line has enabled QuantumScape (NYSE:QS) to initiate commercial sampling and ...